Challenges and controversies in immunization safety

Infectious Disease Clinics of North America

Volumn 15, Issue 1, 2001, Pages 21-39

  Chen, Robert T ^b   DeStefano, Frank ^b   Pless, Robert ^b   Mootrey, Gina ^b   Kramarz, Piotr ^b   Hibbs, Beth ^b  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ASTHMA; AUTISM; DIABETES INSIPIDUS; DIPHTHERIA; DRUG FORMULATION; DRUG SAFETY; GUILLAIN BARRE SYNDROME; HEPATITIS B; HUMAN; IMMUNIZATION; PATIENT INFORMATION; POLIOMYELITIS; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0035062030     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70266-X     Document Type: Article

References (100)

1. Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine
2. Reverse transcriptase activity in chicken-cell derived vaccine
3. Concerns about immunisation
4. The Swedish childhood diabetes study: Vaccinations and infections as risk determinants for diabetes in childhood
5. Field evaluation of a human anthrax vaccine
6. Anthrax
7. Simian virus 40 (SV40): A possible human polyomavirus
8. Cell and molecular biology of simian virus 40: Implications for human infections and disease
9. Simian virus 40, polio vaccines and human tumors: A review of recent developments
10. Bioterrorism alleging use of anthrax and interim guidelines for management - United States, 1998
11. Ten great public health achievements - United States, 1900-1999
12. Impact of vaccines universally recommended for children - United States, 1990-1998
13. Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service
14. Intussusception among recipients of rotavirus vaccine - United States, 1998-1999
15. Recommendations regarding the use of vaccines that contain thimerosal as a preservative
16. Withdrawal of rotavirus vaccine recommendation
17. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
18. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
19. Surveillance for adverse events associated with anthrax vaccination - U.S. Department of Defense, 1998-2000
20. Notice to Readers: Summary of the joint statement on thimerosal in vaccines
21. Measles virus DNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcriptase followed by polymerase chain reaction
22. Investigation of a possible association between influenza vaccination and Guillain-Barré syndrome in the United States, 1990-1991
23. The Vaccine Adverse Event Reporting System (VAERS)
24. The Vaccine Safety Datalink Project: A new tool for improving vaccine safety monitoring in the United States
25. Vaccine adverse events: Causal or coincidental?
26. Vaccine risks: Real, perceived, and unknown
27. Safety of vaccines
28. The Vaccine Safety Datalink: Immunization research in health maintenance organizations in the USA
29. Gallium-67 scintigraphy in macrophagic myofasciitis
30. The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus
31. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: Outcomes at 66 months of age in the Seychelles Child Development Study
32. Hepatitis B and Hib vaccinations and type 1 diabetes
33. Anthrax
34. Immune mechanisms of childhood asthma
35. The complicated task of monitoring vaccine safety
36. New technologies for making vaccines
37. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines
38. Etiologic and therapeutic aspects of intussusception in childhood
39. Postexposure prophylaxis against experimental inhalation anthrax
40. Anthrax vaccine. Evidence for safety and efficacy against inhalational anthrax
41. Impact of anti-vaccine movements on pertussis control: The untold story
42. Macrophagic myofasciitis: An emerging entity
43. MMR and autism
44. Sclerose en plaques et vaccination contre le virus de l'hepatite B
45. Cognitive performance of children prenatally exposed to "safe" levels of methylmercury
46. Combination vaccines: Issues in evaluation of effectiveness and safety
47. Multiple sclerosis and hepatitis B vaccine?
48. Limiting infant exposure to thimerosal in vaccines and other sources of mercury
49. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine
50. The environment and disease: Association or causation?
51. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: Cross sectional study
52. Guillain-Barré syndrome and the 1978-1979 influenza vaccine
53. Anthrax as a biological weapon. Medical and public health management
54. Childhood immunizations and type 1 diabetes: Summary of an Institute for Vaccine Safety Workshop
55. Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys
56. No evidence that vaccines cause insulin dependent diabetes mellitus
57. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981
58. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: Birth cohort study
59. Is infant immunization a risk factor for childhood asthma or allergy?
60. Simultaneous administration of childhood vaccines: An important public health policy that is safe and efficacious
61. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines
62. An attempt to swindle nature: Press reportage of anti-immunisation, Australia 1993-97
63. The introduction of new vaccines into developing countries
64. Parental perceptions of barriers to childhood immunization: Results of focus groups conducted in an urban population
65. Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children
66. A randomized controlled trial of the effect of pertussis vaccines on atopic disease
67. Framing effects on expectations, decision and side effects experienced: The case of influenza immunization
68. Pertussis vaccination and asthma: Is there a link?
69. Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature
70. Does influenza vaccination exacerbate asthma?
71. Measles history and atopic diseases: A population-based cross-sectional study
72. Virus survival in the environment
73. The development of rheumatoid arthritis after recombinant hepatitis b vaccination
74. Immunization status and sociodemographic characteristics: The mediating role of beliefs, attitudes and perceived control
75. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection
76. Invertebrates versus vertebrates innate immunity: In the light of evolution
77. Embryological origins for autism: Developmental anomalies of the cranial nerve motor nuclei
78. Give us this day our daily germs
79. Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988
80. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children
81. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: Results of a two-state study
82. Health consequences of religious and philosophical exemptions from immunization laws, individual and societal risk of measles
83. Guillain-Barré syndrome following vaccination in the national influenza immunization program, United States, 1976-1977
84. Vaccine identification standards initiative
85. Iatrogenic exposure to mercury following hepatitis B vaccination in preterm infants
86. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates
87. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association
88. Evidence of avian leukosis virus subgroup E and endogenous avian virus in measles and mumps vaccines derived from chicken cells: Investigation of transmission to vaccine recipients
89. Anthrax vaccines: Past, present and future
90. Vaccine safety
91. Ileal lymphoid nodular hyperplasia, nonspecific colitis, and regressive developmental disorder in children
92. Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avaian retrovirus RNA
93. Repeated immunization: Possible adverse effects. Reevaluation of human subjects at 25 years
94. Immunization registries in the United States: Implications for the practice of public health in a changing health care system